Oric Pharmaceuticals Stock Options
| ORIC Stock | USD 10.17 0.27 2.73% |
Oric Pharmaceuticals' latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 0.26 with a put-to-call open interest ratio of 0.04 over 5 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 10.0, with calls trading at the volume of 10.0. This yields a 0.33 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
2024-12-20
The chart above shows Oric Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Oric Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Oric Pharmaceuticals' option, there is no secondary market available for investors to trade.
Oric Pharmaceuticals' option chain provides insight into all available option contracts written on Oric Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Oric Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Oric option contract.
In The Money vs. Out of Money Option Contracts on Oric Pharmaceuticals
Analyzing Oric Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Oric Pharmaceuticals regardless of its overall volatility. This is especially true when Oric Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Oric Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Oric Pharmaceuticals' stock while costing only a fraction of its price.
Oric Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Oric Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Oric stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Oric Pharmaceuticals' stock price goes up or down, the stock options follow.
As of December 3, 2024, Common Stock is expected to decline to 3,614. In addition to that, Total Stockholder Equity is expected to decline to about 189.3 MOric Pharmaceuticals In The Money Call Balance
When Oric Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Oric Pharmaceuticals stock is said to be in the money. When it comes to buying Oric Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Oric Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Oric Current Options Market Mood
Oric Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Oric Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Oric Pharmaceuticals' options investors are not very successful. Oric Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Oric contract
Base on the Rule 16, the options market is currently suggesting that Oric Pharmaceuticals will have an average daily up or down price movement of about 0.0163% per day over the life of the 2024-12-20 option contract. With Oric Pharmaceuticals trading at USD 10.17, that is roughly USD 0.001653. If you think that the market is fully incorporating Oric Pharmaceuticals' daily price movement you should consider buying Oric Pharmaceuticals options at the current volatility level of 0.26%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Oric |
Purchasing Oric Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Oric calls. Remember, the seller must deliver Oric Pharmaceuticals stock to the call owner when a call is exercised.
Oric Pharmaceuticals Option Chain
When Oric Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Oric Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Oric Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Oric. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Oric. It also shows strike prices and maturity days for a Oric Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | ORIC Option Call 20-12-2024 10 | 3236 | 2024-12-20 | 0.0 - 0.0 | 0.55 | In |
Call | ORIC Option Call 20-12-2024 12 | 49 | 2024-12-20 | 0.0 - 0.0 | 0.16 | Out |
Call | ORIC Option Call 20-12-2024 15 | 10 | 2024-12-20 | 0.0 - 0.0 | 0.25 | Out |
Put | ORIC Option Put 20-12-2024 5 | 117 | 2024-12-20 | 0.0 - 0.0 | 0.05 | Out |
Put | ORIC Option Put 20-12-2024 10 | 5 | 2024-12-20 | 0.0 - 0.0 | 1.15 | Out |
Oric Total Stockholder Equity
Total Stockholder Equity |
|
Oric Pharmaceuticals Corporate Management
| CPA CPA | Chief Officer | Profile | |
| BA BA | CoFounder Board | Profile | |
| Lori Friedman | Chief Officer | Profile | |
| Esq JD | G Counsel | Profile | |
| MS MD | Chief Officer | Profile | |
| Richard Heyman | Independent CoFounder | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oric Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oric Pharmaceuticals. If investors know Oric will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oric Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Return On Assets (0.29) | Return On Equity (0.46) |
The market value of Oric Pharmaceuticals is measured differently than its book value, which is the value of Oric that is recorded on the company's balance sheet. Investors also form their own opinion of Oric Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oric Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oric Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oric Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oric Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oric Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.